Association of 70-Gene Signature Assay Findings With Physicians’ Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gene Assay

IMPORTANCE: Among patients who undergo the 21-gene assay (21-GA), 39% to 67% receive an intermediate risk result and may receive ambiguous treatment guidance. The 70-gene signature assay (70-GS) may be associated with physicians’ treatment decisions in this population with early breast cancer. OBJEC...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JAMA Oncol
Hlavní autoři: Tsai, Michaela, Lo, Shelly, Audeh, William, Qamar, Rubina, Budway, Raye, Levine, Ellis, Whitworth, Pat, Mavromatis, Blanche, Zon, Robin, Oldham, Dwight, Untch, Sarah, Treece, Tina, Blumencranz, Lisa, Soliman, Hatem
Médium: Artigo
Jazyk:Inglês
Vydáno: American Medical Association 2017
Témata:
Original Investigation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5833645/
https://ncbi.nlm.nih.gov/pubmed/29075751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2017.3470
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky